trialspark.com
Formation Bio is a tech-driven, AI-native pharmaceutical company focused on accelerating drug development to bring new treatments to patients faster and more efficiently. They leverage a proprietary technology platform and AI advancements to improve efficiency across the drug development lifecycle, from drug selection to clinical trials. The company acquires and develops clinical-stage assets through flexible structures and financing pathways. Their multidisciplinary team comprises experts in drug selection, drug development, and technology, with leadership having extensive experience in both pharma and tech industries. Formation Bio aims to transform the drug development industry by building a scalable pharma company that combines the impact of large pharma with the agility of a tech company, ultimately increasing the availability of much-needed treatments.
trialspark.com
Formation Bio is a tech-driven, AI-native pharmaceutical company focused on accelerating drug development to bring new treatments to patients faster and more efficiently. They leverage a proprietary technology platform and AI advancements to improve efficiency across the drug development lifecycle, from drug selection to clinical trials. The company acquires and develops clinical-stage assets through flexible structures and financing pathways. Their multidisciplinary team comprises experts in drug selection, drug development, and technology, with leadership having extensive experience in both pharma and tech industries. Formation Bio aims to transform the drug development industry by building a scalable pharma company that combines the impact of large pharma with the agility of a tech company, ultimately increasing the availability of much-needed treatments.